U.S. Metals and Mining Stock News

NYSE:HLIO
NYSE:HLIOMachinery

A Look At Helios Technologies (HLIO) Valuation After Recent Pullback And Strong One Year Return

Helios Technologies (HLIO) has drawn fresh attention after a recent pullback, with the stock showing a 15.1% decline over the past month and a 13.7% gain in the past 3 months. See our latest analysis for Helios Technologies. At a share price of $63.0, Helios Technologies has given investors a strong 1 year total shareholder return of 88.97%, even as its 30 day share price return of 15.13% and softer recent weekly moves suggest momentum has cooled after a strong run earlier in the year. If...
NYSE:AMH
NYSE:AMHResidential REITs

Assessing American Homes 4 Rent (AMH) Valuation After Recent Share Price Weakness

American Homes 4 Rent: recent stock move and business snapshot American Homes 4 Rent (AMH) has drawn attention after recent share performance, with the stock showing a 2.7% decline over the past day and a 7.2% decline over the past month. The US based REIT owns, develops, renovates and manages more than 61,000 single family rental homes across several regions. It reports revenue of US$1.85b and net income of US$437.70m. See our latest analysis for American Homes 4 Rent. With the share price...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Assessing Paramount Skydance (PSKY) Valuation After Recent Share Price Weakness and Turnaround Hopes

Paramount Skydance (PSKY) is back in focus after recent share price swings, with the stock showing mixed short term performance and sharper declines over the month and past 3 months. See our latest analysis for Paramount Skydance. With the share price at $9.15, the recent 1 day share price return of 2.12% comes after weaker momentum, including a 30 day share price return of a 14.57% decline and a 1 year total shareholder return of a 21.62% loss, pointing to sentiment that has cooled rather...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Should Rett Breakthrough Status and Pivotal Trial Progress Require Action From Taysha Gene Therapies (TSHA) Investors?

Taysha Gene Therapies reported full-year 2025 results on March 19, 2026, posting US$9.77 million in sales versus US$8.33 million a year earlier, alongside a net loss of US$109 million and appointing Brad Martin as Senior Vice President, Market Access and Value in February 2026. At the same time, the company highlighted clinical and regulatory progress for its Rett syndrome program TSHA-102, including FDA Breakthrough Therapy designation, written FDA alignment on pivotal trial design and...
NYSE:LOB
NYSE:LOBBanks

Assessing Live Oak Bancshares (LOB) Valuation After Recent Share Price Pullback

Live Oak Bancshares overview Live Oak Bancshares (LOB) has drawn investor attention after recent price moves, with the stock showing a 22.1% decline over the past month and a 12.1% decline over the past 3 months, despite a 16.9% total return over the past year. See our latest analysis for Live Oak Bancshares. The recent 22.1% 1 month share price decline and 12.1% 3 month share price decline contrast with the 16.9% 1 year total shareholder return, suggesting near term momentum has cooled while...
NYSE:FR
NYSE:FRIndustrial REITs

A Look At First Industrial Realty Trust (FR) Valuation After Recent Share Price Pullback

Recent performance context First Industrial Realty Trust (FR) has seen its share price move lower recently, with a 3.1% decline in the past day, a 5.2% decline over the past week, and an 8.2% decline over the past month. See our latest analysis for First Industrial Realty Trust. Despite the recent weak momentum in the share price, with short term share price returns in negative territory, First Industrial Realty Trust still shows a positive 1 year total shareholder return of 10.2% and a 5...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Nova (NVMI) Is Up 8.6% After Barclays Highlights Metrology Exposure In Initiation Note - Has The Bull Case Changed?

On March 11, 2026, Barclays analyst Tom O'Malley initiated coverage of Nova Ltd. with an “Overweight” rating, citing its exposure to metrology demand as semiconductor manufacturing becomes more measurement intensive. This fresh endorsement underscores how Nova’s broadened metrology portfolio and recent tool qualifications could reinforce its role in the evolving wafer fab equipment ecosystem. We’ll now examine how Barclays’ positive initiation, focused on Nova’s metrology positioning, may...
NYSE:ST
NYSE:STElectrical

A Look At Sensata Technologies Holding (ST) Valuation After Recent Share Price Weakness

Sensata Technologies Holding (ST) has drawn investor attention after recent share price weakness, with the stock showing declines over the past week, month, and past 3 months that contrast with its positive 1 year total return. See our latest analysis for Sensata Technologies Holding. The recent 13.5% decline in the 1 month share price contrasts with a 24.1% 1 year total shareholder return. This suggests that earlier optimism has cooled and momentum has faded in the short term, as investors...
NYSE:XPEV
NYSE:XPEVAuto

XPeng (XPEV) Is Down 12.1% After First-Ever Quarterly Profit Paired With Weak Q1 2026 Outlook

XPeng Inc. has already reported fourth-quarter 2025 results, with revenue rising to CNY 22,253.76 million and net income of CNY 383.21 million, marking its first-ever quarterly profit and sharply narrowing full-year losses compared with 2024. Despite this profitability milestone and strong 2025 delivery growth, management’s guidance for a double-digit revenue and delivery decline in the first quarter of 2026 highlights ongoing pressure from subsidy rollbacks and intense EV competition. Now...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Is Freshpet (FRPT) Losing a Branding Edge as It Retires Its “Human Grade” Dog Food Claims?

Earlier in March 2026, Freshpet was instructed by the National Advertising Division to stop implying its dog food is “human grade” after a challenge from rival The Farmer’s Dog, and the company has said it will comply. This ruling highlights how marketing language around ingredient quality and product positioning can become a competitive battleground in the premium fresh pet food category. Next, we’ll examine how Freshpet’s decision to stop “human grade” claims could influence its branding,...
NYSE:CVX
NYSE:CVXOil and Gas

Berkshire’s Bigger Chevron Bet Puts Oil Volatility And Cash Returns In Focus

Berkshire Hathaway has significantly expanded its stake in Chevron, signaling increased institutional interest in NYSE:CVX. The move comes during a period of oil market volatility and heightened energy sector price swings. Chevron shares most recently closed at $201.73. For investors watching NYSE:CVX, Berkshire Hathaway's larger position highlights Chevron's role as a major integrated energy company with meaningful scale and liquidity. The stock has returned 29.4% year to date and 28.0%...
NasdaqGS:SVRA
NasdaqGS:SVRABiotechs

Assessing Savara (SVRA) Valuation After Recent Share Price Weakness

Why Savara Stock Is Back on Investors’ Radar Savara (SVRA) shares have been under pressure recently, with negative returns over the past week, month and past 3 months. This has prompted investors to reassess this clinical stage rare respiratory disease specialist. See our latest analysis for Savara. While the recent 1 day share price return of 3.88% decline and 90 day share price return of 23.34% decline suggest fading short term momentum, the 1 year total shareholder return of 75.89%...
NYSE:CNP
NYSE:CNPIntegrated Utilities

Assessing CenterPoint Energy (CNP) Valuation After Recent Mixed Returns And Modest Undervaluation Signals

CenterPoint Energy (CNP) is back on investor watch after recent trading showed mixed short term returns, including a 2.8% one day decline alongside a gain over the past 3 months. See our latest analysis for CenterPoint Energy. The latest moves sit within a stronger upward trend, with an 11.16% 90 day share price return and a 20.19% one year total shareholder return suggesting momentum has been building despite recent softness around the US$42.02 level. If you are comparing CenterPoint Energy...
NYSE:JOBY
NYSE:JOBYAirlines

Will Joby’s FAA-Conforming Tests and eVTOL Pilot Program Nod Change Joby Aviation's (JOBY) Narrative?

Earlier in March 2026, Joby Aviation completed piloted electric air taxi demonstration flights around San Francisco Bay, began testing its first FAA-conforming aircraft for Type Inspection Authorization, and was selected to participate in the White House-backed eVTOL Integration Pilot Program across 10 U.S. states. These steps give Joby a path to start early operations in multiple regions while regulators evaluate its aircraft for eventual commercial service, tightening the link between its...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

How Rapport’s Greater China RAP-219 Licensing Deal At Rapport Therapeutics (RAPP) Has Changed Its Investment Story

In March 2026, Rapport Therapeutics announced it had granted Tenacia Biotechnology exclusive rights to develop and commercialize its investigational drug RAP-219 in Greater China, in exchange for a US$20,000,000 upfront payment, up to about US$308,000,000 in potential milestones and other payments, and tiered royalties on future regional sales. Beyond the financial terms, the agreement positions Tenacia to lead Phase 3 trial sites in China for RAP-219 in focal onset seizures, potentially...
NYSE:FUL
NYSE:FULChemicals

A Look At H.B. Fuller (FUL) Valuation After Recent Share Price Slide

What H.B. Fuller’s Recent Share Performance Tells Investors H.B. Fuller (FUL) has drawn attention after a recent share price slide, with the stock down about 25% over the past month and roughly 18% over the past 3 months, prompting closer scrutiny from investors. See our latest analysis for H.B. Fuller. Looking beyond the recent slump, H.B. Fuller’s 30 day share price return of 25.25% and year to date share price return of 18.31% both suggest fading momentum. Meanwhile, the 1 year total...
NYSE:OTIS
NYSE:OTISMachinery

Assessing Otis Worldwide (OTIS) Valuation After Launch Of Viva Accessibility Solutions

Otis Worldwide (OTIS) is putting accessible mobility at the center of its product story, unveiling its Viva elevator solutions aimed at safer, more intuitive rides for aging populations and broader tenant needs worldwide. See our latest analysis for Otis Worldwide. Despite the Viva launch and the upcoming appearance at the JPMorgan Industrials Conference, recent trading has been soft, with a 30 day share price return decline of 14.17% and a 1 year total shareholder return decline of 19.96%,...
NYSE:HPE
NYSE:HPETech

A Look At Hewlett Packard Enterprise (HPE) Valuation After New NVIDIA Backed AI Infrastructure Launches

Hewlett Packard Enterprise (HPE) just rolled out a cluster of AI focused launches and NVIDIA backed partnerships, spanning AI factories, sovereign systems and edge grids, that collectively sharpen its role as an infrastructure supplier. See our latest analysis for Hewlett Packard Enterprise. Despite the flurry of AI factory and sovereign AI announcements, HPE’s 1 day share price return of 1.94% and 90 day share price return of 12.19% suggest momentum has cooled recently, even as 1 year and...
NasdaqGS:UAL
NasdaqGS:UALAirlines

A Look At United Airlines (UAL) Valuation As Fuel Costs Rise And Capacity Is Cut

United Airlines Holdings (UAL) drew fresh investor attention after CEO Scott Kirby warned that sharply higher jet fuel prices tied to Iran tensions are pressuring costs, prompting a 5% cut to near term flight capacity. See our latest analysis for United Airlines Holdings. The recent warning on fuel costs and capacity cuts comes after a weak run in the share price, with a 30 day share price return of 20.42% and a 90 day share price return of 22.47%, even though the 1 year total shareholder...
NYSE:ZTO
NYSE:ZTOLogistics

Is Stronger Earnings And A Larger Buyback Altering The Investment Case For ZTO Express (ZTO)?

ZTO Express (Cayman) Inc. has already reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year on year, and also announced a semi-annual US$0.38 per-share dividend, completion of a US$2.00 billion buyback, and approval of a new US$1.50 billion repurchase plan. Together, the stronger earnings, larger cash returns to shareholders, and confirmation that repurchases will be funded from existing cash highlight management’s confidence in the business and its...
NYSE:JLL
NYSE:JLLReal Estate

Taking A Fresh Look At Jones Lang LaSalle (JLL) Valuation After Recent Share Price Moves

What Jones Lang LaSalle (JLL) offers investors today Jones Lang LaSalle (JLL) sits at the center of global commercial real estate, with a market value of about US$13.8b and a broad mix of fee based services, investment management and technology solutions. See our latest analysis for Jones Lang LaSalle. The recent 1 month share price return of 6.43% and 90 day decline of 13.71% suggest momentum has cooled in the short term. However, the 1 year total shareholder return of 17.40% and 3 year...
NYSE:CHH
NYSE:CHHHospitality

How Ascend’s 500-Property Milestone And China Master Franchise At Choice Hotels (CHH) Has Changed Its Investment Story

In March 2026, Choice Hotels International’s Ascend Hotel Collection passed the 500-property mark, adding new U.S. locations such as The Harrison Hotel in Downtown Hollywood, Florida and The Gould Hotel in Seneca Falls, New York. This expansion is underpinned by a 70-hotel pipeline and fresh international moves into Poland, Chile, Kenya’s Maasai Mara, and a master franchise deal in China adding over 9,500 rooms to the brand. We’ll now examine how Ascend’s 500-property scale and China master...
NYSE:ZBH
NYSE:ZBHMedical Equipment

A Look At Zimmer Biomet (ZBH) Valuation After Revenue Beat EPS Miss And Acquisition Progress

Zimmer Biomet Holdings (ZBH) drew fresh attention after reporting 10.9% year-on-year revenue growth that came in 0.9% above analyst expectations, while slightly missing full-year EPS guidance despite progress on EPS, free cash flow, and acquisitions. See our latest analysis for Zimmer Biomet Holdings. The latest earnings update landed against a weak share price backdrop, with a 30 day share price return showing an 11% decline and a 1 year total shareholder return showing a 19.86% decline...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

Assessing PTC (PTC) Valuation After Recent Weak Share Price Performance

Event context and recent price performance PTC (PTC) shares recently closed at US$149.81, with the stock showing a 0.6% decline over the past day and a 3.9% decline over the past week. This sets the backdrop for investors assessing current levels. See our latest analysis for PTC. While the recent share price return has been weak, with a 16.3% decline over 90 days and an 11.9% decline year to date, the 3 year total shareholder return of 23.1% and 5 year total shareholder return of 10.6% show a...